Bevacizumab
CAS: 216974-75-3
Ref. TM-T9904
1mg | 127.00 € | ||
2mg | 202.00 € | ||
5mg | 374.00 € | ||
10mg | 557.00 € | ||
25mg | 891.00 € | ||
50mg | 1,209.00 € | ||
100mg | 1,625.00 € | ||
200mg | 2,201.00 € |
Product Information
- Bevacizumab(anti-VEGF)
- anti-VEGF
- rhuMab VEGF
- Avastin
Ipilimumab targets CTLA-4, an immune checkpoint inhibitor. Bevacizumab binds to VEGF-A isoforms.
Chemical properties
Technical inquiry about: TM-T9904 Bevacizumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.